Preclinical Evaluation of [¹⁸F]LCATD as a PET Tracer to Study Drug-Drug Interactions Caused by Inhibition of Hepatic Transporters

Figure 3

Maximum intensity coronal projection of livers of a representative control (a), rifamycin SV-treated (b), and fusidate-treated (c) rat at 2, 4, and 8 minutes postinjection.